Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00271739 · ClinicalTrials.gov registry record · NA

Randomized Trial of Telemedicine for Diabetes Care

A NA study of Diabetes Mellitus, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
1,665
Enrollment target
2
Study locations

NCT00271739 is a NA study of Diabetes Mellitus that has completed, run by Columbia University. The registered enrollment target is 1,665 participants, below the 1,859-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (10% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00271739, a NA study of Diabetes Mellitus, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
1,665 participants
Enrollment target
2
Study locations

Study Summary

The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.

Conditions Studied

Interventions

  • OTHER usual care
  • DEVICE Telemedicine Unit (HTU)

Study Locations (2)

New York

  • Columbia University - New York
  • SUNY Upstate Medical University - Syracuse

Trial Details

FieldValue
Enrollment Target 1,665 participants
Start Date 2000-12
Est. Completion 2007-05
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT00271739

The ClinicalTrials.gov registry entry for NCT00271739 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,665 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,859-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (10% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which usual care is the first listed.

NCT00271739 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00271739 about?

NCT00271739 is a clinical study titled "Randomized Trial of Telemedicine for Diabetes Care". The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.

What is the current status of trial NCT00271739?

This trial is currently completed. It is a NA study. The enrollment target is 1,665 participants. The study started on 2000-12. Estimated completion is 2007-05.

What conditions does trial NCT00271739 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00271739?

The interventions under investigation include: usual care (OTHER), Telemedicine Unit (HTU) (DEVICE).

Who is sponsoring clinical trial NCT00271739?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00271739 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.